#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lymphangiosarcoma Marginal zone lymphoma refractory Postprandial hypoglycaemia Osteomyelitis Loeys-Dietz syndrome Graft versus host disease Non-small cell lung cancer metastatic Necrotising myositis Immune thrombocytopenia Malignant oligodendroglioma Haemophilia B with anti factor IX Primary mediastinal large B-cell lymphoma Ewing's sarcoma Arrhythmia Acute on chronic liver failure More trials…

    Learn about Rare Diseases

    Methylmalonic acidaemia Optic glioma – Basic Information Small intestine leiomyosarcoma Hereditary optic atrophy Burkitt’s lymphoma Haemophilia – Basic Information Congenital generalised lipodystrophy – Trials in Disease Angiosarcoma metastatic – Life with Disease Haemophilia B with anti factor IX – Treatment Myelodysplastic syndrome with excess blasts – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cemdisiran Acetylcysteine Adezunap AZD5148 D-Camphor Blomia Tropicalis Mycophenolate Mofetil Bezafibrate Gallium Citrate Ga-68 Dinutuximab Beta Clozapine Bms-986408 Pravastatin Sodium Arachis Hypogaea Extract PIPOTIAZINE LUNRESERTIB Gadoteridol Tetrahydrouridine Ly3484356 Tarlatamab More therapies…

    Learn about Your Condition

    Iron overload Intellectual disability Caesarean section Pyrexia Mesothelioma malignant Lymphocyte adoptive therapy Cough Loeys-Dietz syndrome Round cell liposarcoma Anal cancer recurrent Urticaria chronic Staphylococcal infection Pharyngeal cancer stage III Malignant melanoma stage III Cutaneous T-cell lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Lithuania

  • Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD

    Recruiting

    4 1
    Investigated Drugs:
    • LUNSEKIMIG
    Czechia Germany Greece Lithuania The Netherlands Norway +4
  • Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis

    Recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Croatia Czechia France Greece Hungary Italy +5
  • A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis

    Recruiting

    3 1
    Austria Belgium Bulgaria Croatia Czechia Denmark +15
  • Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

    Recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • SPY002
    Austria Belgium Bulgaria Croatia Czechia France +9
  • A Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Elritercept
    • Epoetin Alfa
    Belgium Bulgaria France Germany Greece Hungary +8
  • A study comparing Rinatabart Sesutecan to other treatments in patients with endometrial cancer who have previously received platinum-based chemotherapy and PD-L1 therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • HUMAN IGG1 KAPPA MONOCLONAL ANTIBODY AGAINST FOLR1 CONJUGATED TO 1-[(2R,3R,4R,5S,52S)-1,2,3,4,5-PENTAHYDROXY-52-{[(2S)-1-{[(2S)-5-CARBAMOYLAMINO-1-OXO-1-{3-[({[(1S,9S)-9-ETHYL-5-FLUORO-9-HYDROXY-4-METHYL10,13-DIOXO-2,3,9,10,13,15-HEXAHYDRO-1H,12HBENZO[DE]PYRANO[3′,4′:6,7]INDOLIZINO[1,2-B]QUINOLIN-1-YL]CARBAMOYL}OXY)METHYL]ANILINO}PENTAN-2-YL]AMINO}-3-METHYL-1-OXOBUTAN-2-YL]CARBAMOYL}-7-[(2S,3R,4R,5R)-2,3,4,5,6-PENTAHYDROXYHEXYL]-46,54-DIOXO10,13,16,19,22,25,28,31,34,37,40,43-DODECAOXA-7,47,53-TRIAZANONAPENTACONTAN-59-YL]-2,5-DIOXOPYRROLIDIN-3-YL
    • Doxorubicin Hydrochloride
    • Paclitaxel
    Belgium Denmark Finland France Germany Greece +5
1 2 3 … 40
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Cisplatin Methotrexate Cytarabine Dexamethasone Etoposide Risankizumab Hydrocortisone Carboplatin Olaparib Paclitaxel Sodium Chloride Venetoclax Apixaban Prednisolone Efgartigimod Alfa Oxaliplatin Prednisone Upadacitinib Lenalidomide Adalimumab Pemetrexed Fluorouracil Ianalumab Mycophenolate Mofetil Enoxaparin Sodium Azacitidine Duvakitug Barzolvolimab Epinephrine Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acquired antithrombin III deficiency Acromegaly Acute coronary syndrome Acute graft versus host disease Acute leukaemia Acute lymphocytic leukaemia Acute myeloid leukaemia Acute myocardial infarction Acute respiratory distress syndrome Adenocarcinoma gastric Adrenogenital syndrome Alport's syndrome Anaemia Antibiotic therapy Arteriosclerosis Asthma Atrial fibrillation Axial spondyloarthritis B-cell lymphoma recurrent B-cell lymphoma refractory B-cell type acute leukaemia Bladder cancer Bronchiectasis Cardiac amyloidosis Cardiac failure Cardiac failure chronic Cardiovascular disorder Cerebrovascular accident prophylaxis Chronic kidney disease Chronic lymphocytic leukaemia Chronic obstructive pulmonary disease Chronic spontaneous urticaria Coagulation factor X level Cold urticaria Colitis ulcerative Colorectal cancer stage IV Conjunctivitis allergic Contraception COVID-19 Critical illness Crohn's disease Cystic fibrosis Dermatitis atopic Diabetic foot infection Dry eye Dyslipidaemia EGFR gene mutation Embolism Embolism venous Endometrial cancer Endometrial cancer metastatic Endometrial cancer recurrent Erosive oesophagitis Erythema migrans Factor IX deficiency Factor VIII deficiency Fallopian tube cancer Familial hypertriglyceridaemia Gastric cancer Glioblastoma multiforme Glomerulonephritis Gout Haemophilia A with anti factor VIII Heparin resistance Hidradenitis Hormone-refractory prostate cancer Hyperchylomicronaemia Hypertension Hypertriglyceridaemia Idiopathic inflammatory myopathy IgA nephropathy Immune thrombocytopenia Infection prophylaxis Influenza Iron deficiency Iron deficiency anaemia Ischaemic stroke Juvenile idiopathic arthritis Lupus nephritis Macular oedema Major depression Malignant melanoma stage II Malignant melanoma stage III Metastatic gastric cancer Metastatic malignant melanoma Microsatellite instability cancer Migraine Multifocal motor neuropathy Multiple sclerosis Multiple sclerosis relapse Myelodysplastic syndrome Myelodysplastic syndrome with excess blasts Myelofibrosis Neoplasm Neoplasm malignant Neovascular age-related macular degeneration Nephrogenic anaemia Nephropathy Neuroblastoma Neurogenic bladder Non-small cell lung cancer Non-small cell lung cancer metastatic Noonan syndrome Oesophageal adenocarcinoma Oesophageal cancer metastatic Oesophageal carcinoma Ovarian cancer Paroxysmal nocturnal haemoglobinuria Partial seizures Peritoneal cancer index Plasma cell myeloma Pneumonia Primary biliary cholangitis Primary myelofibrosis Progressive relapsing multiple sclerosis Prostate cancer Prostate cancer metastatic Proteinuria Psoriatic arthropathy Pulmonary arterial hypertension Pyelonephritis acute Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Retinal vein occlusion Rheumatoid arthritis Rhinitis allergic Schizophrenia Secondary progressive multiple sclerosis Short stature Sjogren's syndrome Skin bacterial infection Small cell lung cancer Small cell lung cancer limited stage Small for dates baby Squamous cell carcinoma of head and neck Status epilepticus Still's disease Systemic lupus erythematosus Systemic scleroderma Thrombosis prophylaxis Transient ischaemic attack Turner's syndrome Type 2 diabetes mellitus Urinary tract infection Varicella

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!